Publication | Closed Access

Treatment with antileukinate, a CXCR2 chemokine receptor antagonist, protects mice against acute pancreatitis and associated lung injury

InflammationAcute Lung InjuryCytokineAnti-inflammatoryInflammatory Lung DiseaseMedicineImmunologyChronic InflammationImmune MediatorPharmacologyMatrikinesLung InjuryAcute Pancreatitis